Who owns DECOY THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Decoy Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Decoy Therapeutics stock

Who bought or sold DECOY THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
UBS Group 546.00 $3.6k 100% Mar 2026
 View chart
Morgan Stanley 1.00 $7.000000 100% Mar 2026
 View chart